Contrast-induced nephropathy: Is the picture any clearer?

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 1, 2008, Pages 261-262

  Rudnick, Michael R ^a,c   Goldfarb, Stanley ^a   Tumlin, James ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Southeast Renal Associates   (United States)

^c Penn Presbyterian Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; CHEMICALLY INDUCED DISORDER; HUMAN; INCIDENCE; REVIEW; RISK FACTOR;

CONTRAST MEDIA; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; RISK FACTORS;

EID: 38749125921     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04951107     Document Type: Article

References (18)

1. Berns AS: Nephrotoxicity of contrast media. Kidney Int 36: 730-740, 1989
2. Rudnick MR, Berns JS, Cohen RM, Goldfarb S: Contrast media-associated nephrotoxicity. Semin Nephrol 17: 15-26, 1997
3. Murray PT, Palevsky PM: Specific syndromes of acute kidney injury: Contrast-induced nephropathy. NephSAP 6: 307-315, 2007
4. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT: Hospital-acquired renal insufficiency: A prospective study. Am J Med 74: 243-248, 1983
5. Shusterman N, Strom BL, Murray TG, Morrison G, West SL, Maislin G: Risk factors and outcome of hospital-acquired acute renal failure: Clinical epidemiologic study. Am J Med 83: 65-71, 1987
6. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB, for the Iohexol Cooperative Study: Nephrotoxicity of high-osmolality versus low-osmolality contrast media: A randomized trial. Kidney Int 47: 254-261, 1995
7. VanZee BE, Hoy WE, Talley TE, Jaenike JR: Renal injury associated with intravenous pyelography in nondiabetic and diabetic patients. Ann Intern Med 89: 51-54, 1978
8. Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A: Renal insufficiency following contrast media administration trial (REMEDIAL): A randomized comparison of 3 preventive strategies. Circulation 115: 1211-1217, 2007
9. Nallamothu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER: Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 117: 938-947, 2004
10. Katzberg RW, Haller C: Contrast-induced nephrotoxicity: Clinical landscape. Kidney Int Suppl 69: S3-S7, 2006
11. Persson PD: Editorial: Contrast medium-induced nephropathy. Nephrol Dial Transplant 20[Suppl 1]: 1, 2005
12. Courtesy of AMR/Arlington Medical Resources, Inc
13. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY: Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 32: 992-999, 1998
14. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 39[Suppl 1]: S46-S64, 2002
15. Rigalleau V, Lasseur C, Perlemoine C, Barthe N, Raffaitin C, Liu C, Chauveau P, Baillet-Blanco L, Beauvieux MC Combe C, Gin H: Estimation of glomerular filtration rate in diabetics: Cockroft formula or Modification of Diet in Renal Disease study equation? Diabetes Care 28: 838-843, 2005
16. Parving HH: Renoprotection in diabetes: Genetic and non-genetic risk factors and treatment. Diabetologia 41: 745-759, 1998
17. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcyteine. N Engl J Med 343: 180-184, 2000
18. Heyman SN, Rosen S, Brezis M: Radiocontrast nephropathy: A paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 2: 153-157, 1994